
News|Podcasts|November 28, 2025
Tracking Tumor Evolution Through MRD and ctDNA
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
4
Up to 5 Cups of Coffee Daily Safe—and Beneficial—for Most Adults
5











































































































